Lorry MDR, also known as the Medical Device Regulation, is a crucial piece of legislation that is set to significantly impact the medical device industry in the European Union. The new regulation, which replaces the Medical Device Directive (MDD) and the Active Implantable Medical Device Directive (AIMDD), aims to enhance the safety and efficacy of medical devices while ensuring a high level of quality and protection for patients.
The Lorry MDR was adopted in April 2017 and will officially come into effect on May 26, 2021. The regulation introduces several key changes that manufacturers, importers, distributors, and notified bodies must adhere to in order to comply with the new requirements. These changes include stricter classification rules, increased scrutiny of clinical evidence, enhanced post-market surveillance obligations, and improved transparency and traceability of medical devices.
One of the most notable aspects of the Lorry MDR is the new classification system for medical devices. Under the new regulation, medical devices will be classified based on their potential risks and intended use, with stricter criteria for higher-risk devices. This new system will have a direct impact on manufacturers, as devices previously classified as low-risk may now fall into a higher-risk category, leading to increased regulatory requirements and stricter oversight.
Another key aspect of the Lorry MDR is the requirement for manufacturers to provide sufficient clinical evidence to demonstrate the safety and efficacy of their medical devices. This includes conducting clinical investigations where necessary and ensuring that the data collected is robust and reliable. Manufacturers will also be required to appoint a Person Responsible for Regulatory Compliance (PRRC) to oversee compliance with the new regulation and to serve as the main point of contact with the competent authorities.
In addition, the Lorry MDR introduces new obligations for post-market surveillance, including the establishment of a comprehensive post-market surveillance plan and the implementation of a risk management system to monitor and address any safety issues that may arise. Manufacturers will also be required to report any adverse events or incidents related to their devices to the competent authorities and to actively monitor the performance of their products once they are on the market.
Transparency and traceability are also key components of the Lorry MDR, as the regulation mandates the creation of a European database on medical devices (EUDAMED) to facilitate the exchange of information between manufacturers, regulators, healthcare professionals, and patients. This database will contain important information about medical devices, including details on their classification, conformity assessments, and clinical investigations, to ensure greater transparency and accountability across the industry.
Overall, the Lorry MDR represents a significant step forward in the regulation of medical devices in the European Union. By enhancing the safety and efficacy of medical devices, improving post-market surveillance and transparency, and strengthening the oversight of notified bodies, the regulation aims to better protect the health and safety of patients while promoting innovation and competitiveness in the medical device industry.
In conclusion, the Lorry MDR is a comprehensive and ambitious piece of legislation that will have far-reaching implications for the medical device industry in the European Union. Manufacturers, importers, distributors, and notified bodies must be prepared to comply with the new requirements, which include stricter classification rules, increased scrutiny of clinical evidence, enhanced post-market surveillance obligations, and improved transparency and traceability of medical devices. By understanding and adhering to the provisions of the Lorry MDR, stakeholders can ensure that they are well-positioned to navigate the changing regulatory landscape and continue to provide safe and effective medical devices to patients across Europe.